DANIEL IBARRA-TAYLOR: Open Payments
NPI 1740514892 · RIVERTON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$81 in 4 payments from 4 companies in 2025. Trend: 2023 $2,893 · 2024 $3,024 · 2025 $81
Food & beverage: $81
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 1 | $34 |
| GENZYME CORPORATION | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: REZDIFFRA, DUPIXENT, VOQUEZNA, ENTYVIO.
Industry payments across UT — which companies pay providers there.
